NVO Novo Nordisk A/S
Healthcare$44.96+1.28%ClosedMarket Cap: $199.79B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$47.00
Target (Median)
$45.00
Target Range
$42.00 - $54.00
Upside from current price: 4.5%
Rating Distribution
1 Strong Buy4 Buy9 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-02 | Goldman Sachs | downgrade | Neutral | Buy |
| 2026-02-24 | JP Morgan | downgrade | Neutral | Overweight |
| 2025-12-08 | Argus Research | downgrade | Hold | Buy |
| 2025-11-28 | Goldman Sachs | maintain | Buy | Buy |
| 2025-11-25 | BMO Capital | maintain | Market Perform | Market Perform |
| 2025-11-24 | HSBC | downgrade | Hold | Buy |
| 2025-10-14 | BMO Capital | maintain | Market Perform | Market Perform |
| 2025-10-02 | HSBC | upgrade | Buy | Hold |
| 2025-09-29 | Morgan Stanley | downgrade | Underweight | Equal Weight |
| 2025-09-17 | Berenberg | upgrade | Buy | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $21.82 | $303.21B | 8 |
| Sun Dec 31 | $23.76 | $325.29B | 7 |
| Mon Dec 31 | $26.75 | $355.58B | 6 |
| Tue Dec 31 | $28.87 | $380.54B | 6 |